Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1998
12/01/1998US5843665 Human pyrophosphatase
12/01/1998CA2016089C Salts of azelastine having improved solubility
12/01/1998CA2009593C Medicament containing dihydrolipoic acid as active substance
11/1998
11/30/1998CA2233554A1 Novel compounds
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052951A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998WO1998052948A1 Compounds for inhibition of ceramide-mediated signal transduction
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998WO1998052934A1 METHOD FOR THE SYNTHESIS OF 8-C-β-D-[2'-O-(E)-CINNAMOYL] GLYCOPYRANOSYL-2-[2-HYDROXY] PROPYL-7-METHOXY-5-METHYLCHROMONE
11/26/1998WO1998052933A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998WO1998052929A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
11/26/1998WO1998052915A2 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998WO1998052914A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998WO1998052579A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998WO1998052553A1 Methods for treatment of conditions associated with lactosylceramide
11/26/1998WO1998052542A1 Medicinal aerosol products
11/26/1998WO1998052539A1 Process for making flurbiprofen lozenges
11/26/1998DE19722848A1 Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular oximo-LTB¶4¶ antagonists
11/26/1998CA2291123A1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2291112A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2290546A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
11/26/1998CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2288327A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998CA2287977A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998CA2287484A1 Compounds for inhibition of ceramide-mediated signal transduction
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production
11/25/1998EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998EP0879605A2 Glycosyl prodrug conjugate with enhanced tolerance
11/25/1998EP0879604A1 Konjugate comprising a Folic acid antagonist and a carrier
11/25/1998EP0879289A1 Human dnase resistant to actin inhibition
11/25/1998EP0879231A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/25/1998EP0879223A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions
11/25/1998EP0663916B1 O-alkylated rapamycin derivative and its use, particularly as immunosuppressant
11/25/1998EP0654994B1 Use of cineol or menthol for the treament of asthma
11/25/1998EP0652866B1 Azacyclic compounds
11/25/1998EP0624159B1 Pyridyl substituted imidazoles
11/25/1998CN1200120A Piperazino derivatives as neurokinin antagonists
11/25/1998CN1200119A (Methylsulfonyl) phenyl-2-(5H)-furanones as cox-2 inhibitors
11/25/1998CN1200115A Chiral methyl phenyl oxazolidinones
11/25/1998CN1199613A Preparation having increased in vivo tolerability
11/25/1998CN1040874C Triazolopyridazine compounds and its preparation, composition with said compound as its active ingredient
11/24/1998US5840974 Metalloproteinase inhibitors
11/24/1998US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors
11/24/1998US5840860 Delivering fatty acid to colon by linking fatty acid to a carbohydrate carrier
11/24/1998US5840842 Receptor-type phosphotyrosine phosphatase-sigma
11/24/1998US5840757 Lipid emulsion intended for parenteral or enteral feeding
11/24/1998US5840725 Substituted oximes, hydrazones and olefins as neurokinin antagonists
11/24/1998US5840713 Therapy for tissue membrane insufficiency
11/24/1998US5840701 Antiischemic agents and macomolecules
11/24/1998US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins
11/24/1998US5840544 DNA encoding rantes homolog from prostate
11/24/1998US5840538 Lgt
11/24/1998US5840535 DNA encoding a zinc ring protein
11/24/1998US5840498 Antibiotic cryptdin peptides and methods of their use
11/24/1998US5840337 Gelling liquid polyethylene glycol at room temperature with calcium acetate
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/24/1998US5840294 Method for treating amyloidosis
11/24/1998US5840277 Treatment of chronic pulmonary inflammation
11/24/1998CA2159591C Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
11/24/1998CA2108584C Substituted azetidinones as anti-inflammatory and antidegenerative agents
11/23/1998CA2232808A1 Novel compounds
11/23/1998CA2230996A1 Novel compounds
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/22/1998CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/19/1998WO1998051706A1 Tumor-associated antigen
11/19/1998WO1998051679A1 Tocopherol esters and their cosmetic and pharmaceutical uses
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051662A2 Compounds and methods for the inhibition of the expression of vcam-1
11/19/1998WO1998051349A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998WO1998051348A2 Sustained-release delayed gels
11/19/1998WO1998051344A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998WO1998051308A1 METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS
11/19/1998WO1998051307A1 METHODS FOR TREATING INFLAMMATION, INFLAMMATORY DISEASES, ARTHRITIS AND STROKE USING pADPRT INHIBITORS
11/19/1998WO1998051289A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998CA2428130A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998CA2290021A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998CA2289448A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998CA2288599A1 Tumor-associated antigen
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998EP0877760A1 Mhc complexes and uses thereof
11/18/1998EP0877737A1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity
11/18/1998EP0877605A2 Solid instant-release forms of administration and process for producing the same
11/18/1998EP0877601A1 Combination injection preparation
11/18/1998EP0713386B1 Spray formulation having a cooling effect
11/18/1998CN1199396A Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases
11/18/1998CN1198929A Composition comprising tramadol material and acetaminophen and its use
11/18/1998CN1040753C Pyridine derivs. and preparation process thereof